Skip to main content
Premium Trial:

Request an Annual Quote

Correction: Nov 23, 2004

Premium

In the 11/16/2004 issue of Inside Bioassays, the article “For Cellomics, Its HCS ‘Boot Camp’ May Have Benefited Customers. But Will It Spur Sales?” mistakenly referred to Amersham Biosciences’ [now GE Healthcare’s] LeadSeeker instrument as the IN Cell Analyzer.